In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels
Tanja Rothgangl(University of Zurich), Gerald Schwank(University of Zurich), Rurika Oka(University of Amsterdam), Anastasia P. Kadina(Synthego (United States)), Denis V. Victorov(Synthego (United States)), Noëlle Bakker(University of Zurich), Markus Stoffel(University of Zurich), Ruben van Boxtel(Oncode Institute), Zacharias Kontarakis(ETH Zurich), Sabina Egli(University of Zurich), John Walker(Synthego (United States)), Sean C. Semple(Arbutus Biopharma (Canada)), Costanza Borrelli(ETH Zurich), Kevin Holden(Synthego (United States)), Paulo J.C. Lin(University of British Columbia), Nina Frey(University of Zurich), Andreas E. Moor(Weizmann Institute of Science), Dominik Witzigmann(FPInnovations), Martina Hruzova(ETH Zurich), Johannes Häberle(University Children's Hospital Zurich), Ying K. Tam(Arbutus Biopharma (Canada)), Melissa K. Dennis(Acuitas Therapeutics (Canada)), Susanne Kreutzer(University of Zurich), Norbert Pardi(University of Pennsylvania), Drew Weissman(California University of Pennsylvania), Beat Thöny(Swiss Integrative Center for Human Health), Martin Pačesa(SIB Swiss Institute of Bioinformatics), Daniela Lenggenhager(University of Zurich), Weihong Qi(University of Zurich), Martin Jínek(University of Zurich), Lucas Kissling(University of Zurich), Lukas Villiger(McGovern Institute for Brain Research)
Cited by 375
Related Papers
mRNA vaccines — a new era in vaccinology
|Nature Reviews Drug Discovery|2018|4.4k
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
|Cell|2014|2.2k
RNA-programmed genome editing in human cells
|eLife|2013|2.1k
DNA interrogation by the CRISPR RNA-guided endonuclease Cas9
|Nature|2014|1.9k